ELMD vs NBIX · P/E 33, rev $73.8M vs P/E 45, rev $1.77B
Electromed Inc (ELMD) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Electromed Inc (ELMD) is a medical devices company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ELMD revenue for 2026-06-30 was $73.8M. Net income was $11.3M. Revenue was up 15.3% from 2025-06-30 to 2026-06-30. ELMD currently screens at market cap $316.8M and trailing P/E 32.7.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ELMD currently screens at market cap $316.8M and trailing P/E 32.7. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ELMD and NBIX stock pages for the full models.
Not investment advice.